A new long-term study published in Otolaryngology–Head and Neck Surgery , the official peer-reviewed journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), suggests that benign paroxysmal positional vertigo (BPPV) may continue to affect patients years after successful initial treatment....
Audiologists and vestibular clinicians should consider longer-term follow-up for patients with a history of BPPV, even after successful repositioning, as the condition may be associated with ongoing systemic or vestibular health risks beyond the acute episode.
This seven-year longitudinal finding challenges the common clinical assumption that successful canalith repositioning fully resolves patient risk, potentially expanding the audiologist's role in long-term vestibular health monitoring.
- 01Seven-year longitudinal study tracked patients after successful BPPV repositioning treatment.
- 02Patients showed elevated long-term health risks despite resolution of acute BPPV symptoms.
- 03Published in peer-reviewed journal Otolaryngology–Head and Neck Surgery.
- 04Findings question the 'treat and discharge' model for BPPV management.
- 05Suggests a need for extended follow-up protocols for BPPV patients.
BPPV carries long-term health risks even after successful canalith repositioning treatment.
studypartially supported- Journal
- Otolaryngology–Head and Neck Surgery
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients diagnosed with BPPV who received successful canalith repositioning treatment, followed longitudinally
- Intervention
- Successful canalith repositioning for BPPV
Primary outcomes
Long-term health outcomes following successful BPPV repositioning treatment over a seven-year period